SK bioscience, IDT Biologika, and Vaxxas will collaborate on a next-generation influenza vaccine development initiative.

Yonsei University researchers have developed a system for combining the benefits of planar array platforms with those of ...

SK bioscience announced that, together with IDT Biologika (IDT) and Australian biotechnology company Vaxxas, it has been selected for Phase 1 of a next-generation vaccine development initiative ...

Persistence Market Research, a leading management consulting firm, has released this update on the dental burs market. Dental burs ...

The panel ensures compatibility with our previous autosomal Family Finder tests plus all the autosomal transfers we ...

New commercial kit brings Nature Communications-validated methylation analysis chemistry to researchers working with low-input and cfDNA samplesCAMBRIDGE, ...

BioVenic is dedicated to advancing the advancement of veterinary molecular diagnostics through its comprehensive ...